Form 4: Eastman Chemical Co Director Brett D. Begemann Reports Changes in Beneficial Ownership

Director Brett D. Begemann reports acquisition of phantom stock units through director's deferred compensation plan.

Summary

• Brett D. Begemann, a director at Eastman Chemical Co, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of phantom stock units under the Directors' Deferred Compensation Plan.
• On April 7, 2025, 1,134 phantom stock units were credited, valued at $73.65 each, due to voluntary deferral of retainer fees.
• An additional 412 phantom stock units were automatically deferred from annual retainer fees on the same date.
• Following these transactions, Begemann's direct holdings include 51,215 phantom stock units.
• These units are payable in cash after termination of service as a director and represent the value of Eastman Chemical Co common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director is increasing their stake in the company, which can be seen as a positive sign. However, it's a routine transaction related to deferred compensation.

Positives

• The director's participation in the deferred compensation plan demonstrates alignment with the company's long-term performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Directors often participate in deferred compensation plans as a way to align their interests with the long-term performance of the company. This is a common practice among publicly traded companies.

Comparison to Industry Standards

• Deferred compensation plans for directors are a common practice in publicly traded companies, often involving stock or phantom stock units.
• The specifics of these plans, such as deferral rates and vesting schedules, can vary widely based on company size, industry, and governance practices.
• Comparing Eastman Chemical's plan to those of its peers (e.g., Dow, BASF, LyondellBasell) would require a detailed analysis of their respective compensation disclosures.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals director confidence in the company's future.

Key Dates

Keywords

Form 4, Beneficial Ownership, Eastman Chemical Co, Director, Phantom Stock Units, Deferred Compensation, EMN